Active

K-FARMA

Switched

BE1001785712

Rechtspersoon Private limited company 1 establishment

Heiblok 14, 2242 Zandhoven Detailhandel in farmaceutische producten

Active for

2 year, 10 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 213,093

▲ 101% vs 2024

Profit

Growing

€ 122,831

▲ 204% vs 2024

Debts

High

€ 1.8 million

▼ 6% vs 2024

K-FARMA from Zandhoven, company number BE1001785712, closed financial year 2025 with a result of € 122,831 after tax. For that financial year K-FARMA recorded a gross margin of € 213,093 and equity of € 168,173. Compared with financial year 2024, the result moved from € 40,342 to € 122,831. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.

What happened at K-FARMA?

What happened at K-FARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 122,831 (▲ 204% vs 2024). Source: NBB ↗
  • New establishment in Zandhoven. KBO
  • Start of the company according to the CBE. KBO

In short

From € 40,342 profit in 2024 to € 122,831 profit in 2025.

Paid € 45,637 in corporate taxes since 2024.

Best year ever: 2025, with € 122,831 profit.

A new publication or filing at K-FARMA? We notify you, reason included.

Follow K-FARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Kaat Van Der Steen
K-FARMA

Behind K-FARMA is Kaat Van Der Steen. It owns 75.1% of Apotheek De Zwaantjes itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Kaat Van Der Steen

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Heiblok 14

2242 Zandhoven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1001.785.712
VAT number
BE 1001.785.712
Registered office
Heiblok 14, 2242 Zandhoven
Names & denominations
K-FARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
30 October 2023
Peppol
Active · Active since 3 Jul 2025
Activities · NACE

Detailhandel in farmaceutische producten

Vervaardiging van geneesmiddelen

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Overige zakelijke dienstverlening, neg

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Frequently asked questions

What is the enterprise number of K-FARMA?
The enterprise number of K-FARMA is BE1001785712.
What is the address of K-FARMA?
The registered office of K-FARMA is located at Heiblok 14, 2242 Zandhoven.
When was K-FARMA founded?
K-FARMA was founded on 30 October 2023.
What is the main activity of K-FARMA?
The main activity of K-FARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does K-FARMA have a website?
No website is currently known for K-FARMA.
How much profit did K-FARMA make in 2025?
K-FARMA posted a profit after taxes of € 122,831 in financial year 2025.
What is the revenue of K-FARMA?
As a small company, K-FARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 213,093.
How many employees does K-FARMA have?
According to the 2025 annual accounts, K-FARMA has 0 full-time equivalents (FTE).
Where can I find the annual accounts of K-FARMA?
K-FARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of K-FARMA?
According to the 2025 annual accounts, the directors of K-FARMA are: Kaat Van Der Steen.
Who owns K-FARMA?
Behind K-FARMA is Kaat Van Der Steen. It owns 75.1% of Apotheek De Zwaantjes itself.